Jeffrey Holford analyst

Currently out of the existing stock ratings of Jeffrey Holford, 73 are a BUY (81.11%), 15 are a HOLD (16.67%), 2 are a SELL (2.22%).

Jeffrey Holford

Work Performance Price Targets & Ratings Chart

Analyst Jeffrey Holford works with a stock forecast success ratio of 100% fulfilled within 895.13 days on average. Previously, Jeffrey Holford worked at JEFFERIES.

Jeffrey Holford’s has documented 139 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on MRK, Merck mpany at 14-Feb-2018.

Wall Street Analyst Jeffrey Holford

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 9/7/2017. The price target of $94 was fulfilled within 141 days with a profit of $32.11 (51.88%) receiving and performance score of 3.68.

Average potential price target upside

ABBV AbbVie ABT Abbott Laboratories AZN AstraZeneca PLC ADR BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer JNJ Johnson & Johnson ZTS Zoetis

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

189

$10.19 (5.70%)

181

22 days ago

9/13 (69.23%)

$20.33 (12.05%)

256

Buy

185

$6.19 (3.46%)

175

22 days ago

11/12 (91.67%)

$16.33 (9.68%)

140

Buy

195

$16.19 (9.05%)

180

22 days ago

7/10 (70%)

$26.33 (15.61%)

402

Hold

156

$-22.81 (-12.76%)

167

2 months 10 days ago

2/2 (100%)

$2.58 (1.68%)

109

Buy

173

$-5.81 (-3.25%)

122

2 months 17 days ago

1/3 (33.33%)

$21.76 (14.39%)

58

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jeffrey Holford?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?